Apixaban-induced liver injury. - Wikidata - awgldk - TriplyDB

Apixaban-induced liver injury.

Apixaban-induced liver injury.

http://www.wikidata.org/entity/Q40533024

about

Apixaban-induced liver injury.

http://www.wikidata.org/entity/Q40533024

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Apixaban-induced liver injury.

@en

type

label

Apixaban-induced liver injury.

@en

prefLabel

Apixaban-induced liver injury.

@en

P1433

Q40533024-FF2402D6-C175-49E0-BF12-5EC55F8C954A

P1476

Q40533024-58FCA09E-3A4C-48BA-B268-6508FDC2DC0D

P2093

Q40533024-0A2EC665-E2CC-49B7-BFDC-58454A9ED48C

Q40533024-9A247875-B287-4445-80BB-9ACA028D0B87

Q40533024-D1D57264-FA74-4602-99FF-E0E6246B55DF

Q40533024-E5DCCC83-5CD2-4A89-B2E6-48902B87FF12

P2860

Q40533024-074006CC-5423-497A-AAA5-EC45683F0DEF

Q40533024-39DAFBBA-1C93-47F4-AE65-59B472794577

Q40533024-5F1557A4-D54F-4D6C-B82F-92884C000937

Q40533024-65BBC738-96EF-4C4C-ABF1-1D26EF684838

Q40533024-6672F504-ADA1-45B5-B978-83A8CCF818BD

Q40533024-684D0860-359E-4482-9305-88940EB5933D

Q40533024-7ADE56D0-78FB-42C3-B436-4AD72B547D38

Q40533024-88C08FA4-F74B-43C8-BD98-0EF439807948

Q40533024-D61F5833-D43C-4BEF-85FF-E5B13F626204

Q40533024-DB0AA288-E1C8-4111-BEE8-0F2B523EF187

P31

Q40533024-2ced4ea7-0365-49b0-9d9b-f97d91aa0321

Q40533024-3F342D29-0B89-45B8-913B-3C0E4FE9A07A

P356

Q40533024-C05D22BF-4072-40CA-9534-858308749CA7

P478

Q40533024-B433DD43-ADEA-4E6D-9F58-427B1CAC5E14

P577

Q40533024-B9D3C32B-F8E3-4F54-BD3C-9FA664AB5E2F

P698

Q40533024-E5845E00-536D-4550-AFFA-71111432D4F5

P932

Q40533024-6FB41862-19E4-41C9-8342-A1190CAA1DDC

P356

BCR-2016-216744

P1433

BMJ case reports

P1476

Apixaban-induced liver injury.

@en

P2093

Ali A Alsaad

http://www.w3.org/2001/XMLSchema#string

Anwar Mack

http://www.w3.org/2001/XMLSchema#string

Michael B Phillips

http://www.w3.org/2001/XMLSchema#string

Sherri-Anne Clarke

http://www.w3.org/2001/XMLSchema#string

P2860

Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury

Use of Hy's Law, R criteria, and nR criteria to predict acute liver failure or transplantation in patients with drug-induced liver injury

Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method

Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug-induced liver injury.

New oral anticoagulants: comparative pharmacology with vitamin K antagonists.

Anticoagulant therapy with the oral direct factor Xa inhibitors rivaroxaban, apixaban and edoxaban and the thrombin inhibitor dabigatran etexilate in patients with hepatic impairment.

Apixaban: a review of its use for reducing the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.

Risk of drug-induced liver injury with the new oral anticoagulants: systematic review and meta-analysis.

Hepatotoxicity of New Oral Anticoagulants (NOACs).

An Observational Study of the Factor Xa Inhibitors Rivaroxaban and Apixaban as Reported to Eight Poison Centers.

P31

scholarly article

P356

10.1136/BCR-2016-216744

http://www.w3.org/2001/XMLSchema#string

P478

2016

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27651407

http://www.w3.org/2001/XMLSchema#string

P932

5030527

http://www.w3.org/2001/XMLSchema#string